Pharmacological and dietary prevention for colorectal cancer

BMC Surgery

Volumn 13, Issue SUPPL.2, 2013, Pages

  Nolfo, Francesca ^a   Rametta, Stefania ^a   Marventano, Stefano ^a   Grosso, Giuseppe ^a   Mistretta, Antonio ^a   Drago, Filippo ^b   Gangi, Santi ^c   Basile, Francesco ^c   Biondi, Antonio ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; CALCIUM; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; TRACE ELEMENT;

COLORECTAL TUMOR; DIET; HUMAN; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASPIRIN; CALCIUM; COLORECTAL NEOPLASMS; DIET; FOLIC ACID; HUMANS; MICRONUTRIENTS; PROBIOTICS;

EID: 84885349999     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-13-S2-S16     Document Type: Article

References (131)

1. A public health approach to winning the war against cancer. Frieden TR, Myers JE, Krauskopf MS, Farley TA, The oncologist 2008 13 12 1306 1313 19091779
2. Major postoperative complications and survival for colon cancer elderly patients. Grosso G, Biondi A, Marventano S, Mistretta A, Calabrese G, Basile F, BMC surgery 2012 12 Suppl 1 20 23173563
3. Laparoscopic-assisted versus open surgery for colorectal cancer: short- and long-term outcomes comparison. Biondi A, Grosso G, Mistretta A, Marventano S, Toscano C, Gruttadauria S, Basile F, Journal of laparoendoscopic & advanced surgical techniques Part A 2013 23 1 1 7 24022235
4. [The use of laparoscopy for diagnosis and stadiation of the lymphomas]. Biondi A, Motta S, Di Giunta M, Crisafi RM, Zappala S, Rapisarda D, Basile F, Annali italiani di chirurgia 2009 80 6 445 447 20476676
5. Clinical rescue evaluation in laparoscopic surgery for hepatic metastases by colorectal cancer. Biondi A, Tropea A, Basile F, Surgical laparoscopy, endoscopy & percutaneous techniques 2010 20 2 69 72 24023495
6. [Management of early rectal cancer: our clinical experience]. Biondi A, Tropea A, Monaco G, Musumeci N, Benfatto G, Basile F, Il Giornale di chirurgia 2011 32 12 34 36 21352705
7. Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems. Vacante M, D'Agata V, Motta M, Malaguarnera G, Biondi A, Basile F, Malaguarnera M, Gagliano C, Drago F, Salamone S, BMC surgery 2012 12 Suppl 1 36 23173707
8. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW, CA: a cancer journal for clinicians 2013 63 2 88 105
9. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA: a cancer journal for clinicians 2011 61 2 69 90
10. Serrated lesions of the colorectum: review and recommendations from an expert panel. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, et al. The American journal of gastroenterology 2012 107 9 1315 1329 quiz 1314, 1330 22710576
11. Low rectal cancer treatment in frail elderly patients. A personal series. Benfatto G, Biondi A, Di Stefano G, Basile G, Jiryis A, Strano G, Mugavero F, Cinardi N, Benfatto SM, Il Giornale di chirurgia 2007 28 5 203 208 17547786
12. Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors. Ragusa M, Statello L, Maugeri M, Majorana A, Barbagallo D, Salito L, Sammito M, Santonocito M, Angelica R, Cavallaro A, et al. J Mol Med (Berl) 2012 90 12 1421 1438
13. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment. Ragusa M, Majorana A, Statello L, Maugeri M, Salito L, Barbagallo D, Guglielmino MR, Duro LR, Angelica R, Caltabiano R, et al. Molecular cancer therapeutics 2010 9 12 3396 3409 20881268
14. From willow bark to acetylsalicylic acid. Norn S, Permin H, Kruse PR, Kruse E, Dansk medicinhistorisk arbog 2009 37 79 98 20509453
15. Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds-gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Lanas A, McCarthy D, Voelker M, Brueckner A, Senn S, Baron JA, Drugs in R&D 2011 11 3 277 288 24023517
16. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, et al. The New England journal of medicine 1983 309 7 396 403 6135989 (Pubitemid 13033964)
17. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Dube C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D, Annals of internal medicine 2007 146 5 365 375 17339622 (Pubitemid 351650597)
18. Aspirin use to be banned in under 16 year olds. Macdonald S, BMJ 2002 325 7371 988 12411347
19. Drug-eluting stents in a patient with favism: is the aspirin administration safe? Rigattieri S, Silvestri P, Minucci A, Di Russo C, Ferraiuolo G, Giardina B, Capoluongo E, Loschiavo P, J Cardiovasc Med (Hagerstown) 2008 9 11 1159 1162
20. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW, Lancet 2011 377 9759 31 41 21144578
21. Risk factors for fatal colon cancer in a large prospective study. Thun MJ, Calle EE, Namboodiri MM, Flanders WD, Coates RJ, Byers T, Boffetta P, Garfinkel L, Heath CW Jr, Journal of the National Cancer Institute 1992 84 19 1491 1500 1433333
22. Epidemiology of colorectal adenomatous polyps. Neugut AI, Jacobson JS, De Vivo I, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1993 2 2 159 176 24021221
23. Do NSAIDs prevent colorectal cancer? Arber N, Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000 14 4 299 307 10799083 (Pubitemid 30265374)
24. Aspirin use and reduced risk of fatal colon cancer. Thun MJ, Namboodiri MM, Heath CW Jr, The New England journal of medicine 1991 325 23 1593 1596 1669840
25. Aspirin dose and duration of use and risk of colorectal cancer in men. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS, Gastroenterology 2008 134 1 21 28 18005960 (Pubitemid 350309311)
26. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS, JAMA: the journal of the American Medical Association 2005 294 8 914 923 (Pubitemid 41215460)
27. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, et al. The New England journal of medicine 2003 348 10 883 890 12621132 (Pubitemid 36297996)
28. A randomized trial of aspirin to prevent colorectal adenomas. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, et al. The New England journal of medicine 2003 348 10 891 899 12621133 (Pubitemid 36297997)
29. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR, Gastroenterology 2008 134 1 29 38 18022173 (Pubitemid 350309319)
30. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S, Gastroenterology 2003 125 2 328 336 12891533 (Pubitemid 36929412)
31. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. Burn J, Bishop DT, Mecklin JP, Macrae F, Moslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, et al. The New England journal of medicine 2008 359 24 2567 2578 19073976
32. Results of the CAPP1 study: aspirin and resistant starch are beneficial in familial adenomatous polyposis. Burn J, Chapman PD, Bishop DT, Fam Cancer 2003 2 42 45
33. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE, JAMA: the journal of the American Medical Association 2005 294 1 47 55 (Pubitemid 41002838)
34. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH, Journal of the National Cancer Institute 1993 85 1220 1224 8331682 (Pubitemid 23223527)
35. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. Farrell B, Godwin J, Richards S, Warlow C, Journal of neurology, neurosurgery, and psychiatry 1991 54 12 1044 1054 1783914
36. Randomised trial of prophylactic daily aspirin in British male doctors. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al. Br Med J (Clin Res Ed) 1988 296 6618 313 316 (Pubitemid 18042841)
37. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Flossmann E, Rothwell PM, Lancet 2007 369 9573 1603 1613 17499602 (Pubitemid 46710123)
38. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, Logan RF, Rothwell PM, Schror K, Baron JA, Cancer Prev Res (Phila) 2012 5 2 164 178
39. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. Patrono C, Patrignani P, Garcia Rodriguez LA, The Journal of clinical investigation 2001 108 1 7 13 11435450 (Pubitemid 32634915)
40. Translational studies on Cox-2 inhibitors in the prevention and treatment of colon cancer. Gupta RA, DuBois RN, Annals of the New York Academy of Sciences 2000 910 196 204 discussion 204-196 10911914
41. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Dannenberg AJ, Zakim D, Seminars in oncology 1999 26 5 499 504 10528897 (Pubitemid 29483274)
42. Acetylsalicyclic acid. Schror K, 2009 Weinheim, Germany: WILEY-VCH Verlag GmbH & Co. KGaA
43. Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology? Ruschoff J, Dietmaier W, Bocker T, Wallinger S, Kullmann F, Beham A, Hofstadter F, Der Pathologe 1998 19 4 269 278 9746911 (Pubitemid 28377526)
44. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Babbar N, Gerner EW, Casero RA Jr, The Biochemical journal 2006 394 Pt 1 317 324 16262603 (Pubitemid 43259681)
45. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Martinez ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, et al. Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7859 7864 12810952 (Pubitemid 36760060)
46. Onsenal: EPAR summary for the public. http://www.ema.europa.eu/docs/en- GB/document-library/EPAR-Summary-for-the-public/human/000466/WC500044631.pdf
47. Primary chemoprevention of familial adenomatous polyposis with sulindac. Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, et al. The New England journal of medicine 2002 346 14 1054 1059 11932472 (Pubitemid 34984619)
48. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ, The New England journal of medicine 1993 328 18 1313 1316 8385741 (Pubitemid 23131373)
49. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK, The British journal of surgery 1993 80 12 1618 1619 8298943 (Pubitemid 24007679)
50. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P, Gastroenterology 1991 101 3 635 639 1650315
51. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, et al. The New England journal of medicine 2000 342 26 1946 1952 10874062 (Pubitemid 30419089)
52. Celecoxib for the prevention of colorectal adenomatous polyps. Arber N, Eagle CJ, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, et al. The New England journal of medicine 2006 355 9 885 895 16943401 (Pubitemid 44315981)
53. Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial. Iwama T, Akasu T, Utsunomiya J, Muto T, International journal of clinical oncology 2006 11 2 133 139 16622748
54. Celecoxib for the prevention of sporadic colorectal adenomas. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, et al. The New England journal of medicine 2006 355 9 873 884 16943400 (Pubitemid 44315980)
55. Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Arber N, Spicak J, Racz I, Zavoral M, Breazna A, Gerletti P, Lechuga MJ, Collins N, Rosenstein RB, Eagle CJ, et al. The American journal of gastroenterology 2011 106 6 1135 1146 21503000
56. Angiostatic Properties of Sulindac and Celecoxib in the Experimentally Induced Inflammatory Colorectal Cancer. Vaish V, Piplani H, Rana C, Sanyal SN, Cell biochemistry and biophysics 2012
57. Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis. Lee Y, Kim H, Kim W, Yoon JH, Jeong SH, Jung Y, Journal of drug targeting 2012 20 6 524 534 22632102
58. The use of high-selenium yeast to raise selenium status: how does it measure up? Rayman MP, The British journal of nutrition 2004 92 4 557 573 15522125 (Pubitemid 39406638)
59. Selenium in the environment, metabolism and involvement in body functions. Mehdi Y, Hornick JL, Istasse L, Dufrasne I, Molecules 2013 18 3 3292 3311 23486107
60. Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? Bera S, De Rosa V, Rachidi W, Diamond AM, Mutagenesis 2013 28 2 127 134 23204505
61. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Sanmartin C, Plano D, Sharma AK, Palop JA, International journal of molecular sciences 2012 13 8 9649 9672 22949823
62. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. JAMA: the journal of the American Medical Association 1996 276 24 1957 1963 (Pubitemid 26427723)
63. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. JAMA: the journal of the American Medical Association 2009 301 1 39 51
64. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, et al. Journal of the National Cancer Institute 2006 98 14 974 983 16849680 (Pubitemid 44288162)
65. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Estaquio C, Hercberg S, International journal of cancer Journal international du cancer 2005 116 2 182 186 15800922 (Pubitemid 40967253)
66. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C, Lancet 2004 364 9441 1219 1228 15464182 (Pubitemid 39311342)
67. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR, International journal of cancer Journal international du cancer 2006 118 7 1777 1781 16217756 (Pubitemid 43376443)
68. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster CB, Schatzkin A, Hayes RB, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 15 2 315 320 24021221 (Pubitemid 43342181)
69. Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial. Bonelli L, Puntoni M, Gatteschi B, Massa P, Missale G, Munizzi F, Turbino L, Villanacci V, De Censi A, Bruzzi P, Journal of gastroenterology 2012
70. British National Formulary. http://www.bnf.org
71. The versatility and universality of calcium signalling. Berridge MJ, Lipp P, Bootman MD, Nature reviews Molecular cell biology 2000 1 1 11 21 11413485
72. Calcium-regulated protein kinase cascades and their transcription factor targets. Cruzalegui FH, Bading H, Cellular and molecular life sciences: CMLS 2000 57 3 402 410 10823241 (Pubitemid 30223567)
73. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Lamprecht SA, Lipkin M, Annals of the New York Academy of Sciences 2001 952 73 87 11795445 (Pubitemid 34060011)
74. Preclinical and early human studies of calcium and colon cancer prevention. Lipkin M, Annals of the New York Academy of Sciences 1999 889 120 127 10668488 (Pubitemid 30040431)
75. Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, Cross HS, Cancer detection and prevention 2000 24 2 127 136 10917132 (Pubitemid 30427698)
76. Association between CASR Polymorphisms, Calcium Intake, and Colorectal Cancer Risk. Kim KZ, Shin A, Kim J, Park JW, Park SC, Choi HS, Chang HJ, Kim DY, Oh JH, PloS one 2013 8 3 59628 23555732
77. Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Thomas MG, Thomson JP, Williamson RC, The British journal of surgery 1993 80 4 499 501 8388307 (Pubitemid 23116096)
78. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J, Lancet 2000 356 9238 1300 1306 11073017
79. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, et al. The New England journal of medicine 1999 340 2 101 107 9887161 (Pubitemid 29054844)
80. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, Larsen S, Osnes M, Digestion 1998 59 2 148 156 9586828 (Pubitemid 128721422)
81. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM, Cancer epidemiology 2013 37 3 278 283 23491770
82. Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Bristow SM, Bolland MJ, Maclennan GS, Avenell A, Grey A, Gamble GD, Reid IR, The British journal of nutrition 2013 1 10
83. Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Park SY, Murphy SP, Wilkens LR, Nomura AM, Henderson BE, Kolonel LN, American journal of epidemiology 2007 165 7 784 793 17215380 (Pubitemid 46434607)
84. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A, Archives of internal medicine 2009 169 4 391 401 19237724
85. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, et al. Journal of the National Cancer Institute 2004 96 13 1015 1022 15240785 (Pubitemid 39162644)
86. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Huncharek M, Muscat J, Kupelnick B, Nutrition and cancer 2009 61 1 47 69 19116875
87. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP, The American journal of clinical nutrition 2007 85 6 1586 1591 17556697 (Pubitemid 46890428)
88. Calcium plus vitamin D supplementation and the risk of colorectal cancer. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, et al. The New England journal of medicine 2006 354 7 684 696 16481636 (Pubitemid 43247139)
89. Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Flood A, Peters U, Chatterjee N, Lacey JV, Schairer C, Schatzkin A, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 14 1 126 132 24021221 (Pubitemid 40165292)
90. Folate and vitamin B12. Scott JM, The Proceedings of the Nutrition Society 1999 58 2 441 448 10466189
91. Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women. World Health Organization (WHO), Geneva 2012
92. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. Duthie SJ, Journal of inherited metabolic disease 2011 34 1 101 109 20544289
93. Folate and carcinogenesis: an integrated scheme. Choi SW, Mason JB, The Journal of nutrition 2000 130 2 129 132 10720158 (Pubitemid 30073783)
94. The influence of folate supplementation on global gene expression in normal colonic mucosa of subjects with colorectal adenoma. Pufulete M, Abbadi RA, Arno M, Ewins M, Green C, Astarloa EA, Sanders T, Emery P, Molecular nutrition & food research 2013 57 4 709 720 24021933
95. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER, Journal of the National Cancer Institute 1998 90 1 57 62 9428784 (Pubitemid 28078082)
96. Folate, methionine, and alcohol intake and risk of colorectal adenoma. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC, Journal of the National Cancer Institute 1993 85 11 875 884 8492316 (Pubitemid 23157127)
97. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE, JAMA: the journal of the American Medical Association 2008 300 17 2012 2021
98. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. Jaszewski R, Misra S, Tobi M, Ullah N, Naumoff JA, Kucuk O, Levi E, Axelrod BN, Patel BB, Majumdar AP, World journal of gastroenterology: WJG 2008 14 28 4492 4498 18680228
99. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Zhu S, Mason J, Shi Y, Hu Y, Li R, Wahg M, Zhou Y, Jin G, Xie Y, Wu G, et al. Chinese medical journal 2003 116 1 15 19 12667380 (Pubitemid 36432714)
100. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, et al. JAMA: the journal of the American Medical Association 2007 297 21 2351 2359 (Pubitemid 46883748)
101. Folic acid supplementation and cancer risk: A meta-analysis of randomized controlled trials. Qin X, Cui Y, Shen L, Sun N, Zhang Y, Li J, Xu X, Wang B, Huo Y, Wang X, International journal of cancer Journal international du cancer 2013
102. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. (EN) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Food and Agriculture Organization (FAO), World Health Organization (WHO), 2001
103. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Geier MS, Butler RN, Howarth GS, Cancer biology & therapy 2006 5 10 1265 1269 24024173 (Pubitemid 44772248)
104. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Ma EL, Choi YJ, Choi J, Pothoulakis C, Rhee SH, Im E, International journal of cancer Journal international du cancer 2010 127 4 780 790 19876926
105. Protective role of probiotics and prebiotics in colon cancer. Wollowski I, Rechkemmer G, Pool-Zobel BL, The American journal of clinical nutrition 2001 73 2 Suppl 451S 455S 11157356 (Pubitemid 32114158)
106. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al. The American journal of clinical nutrition 2007 85 2 488 496 17284748 (Pubitemid 46220953)
107. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt KA, Hu Y, Irahara N, Ogino S, et al. The American journal of clinical nutrition 2009 90 3 578 586 19640954
108. Potential role of probiotics on colorectal cancer prevention. Uccello M, Malaguarnera G, Basile F, D'Agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A, BMC surgery 2012 12 Suppl 1 35 23173670
109. Effects of Vitamin C on health: a review of evidence. Grosso G, Bei R, Mistretta A, Marventano S, Calabrese G, Masuelli L, Giganti MG, Modesti A, Galvano F, Gazzolo D, Frontiers in bioscience 2013 18 1017 29
110. Isoflavones: estrogenic activity, biological effect and bioavailability. Vitale DC, Piazza C, Melilli B, Drago F, Salomone S, European journal of drug metabolism and pharmacokinetics 2013 38 1 15 25 23161396
111. Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Li Volti G, Salomone S, Sorrenti V, Mangiameli A, Urso V, Siarkos I, Galvano F, Salamone F, Cardiovascular diabetology 2011 10 62 21756303
112. Red orange: experimental models and epidemiological evidence of its benefits on human health. Grosso G, Galvano F, Mistretta A, Marventano S, Nolfo F, Calabrese G, Buscemi S, Drago F, Veronesi U, Scuderi A, Oxidative medicine and cellular longevity 2013 2013 157240 23738032
113. Influence of vitamin E on platelet function in humans. Steiner M, Journal of the American College of Nutrition 1991 10 5 466 473 1955623
114. Vitamin D: an evidence-based review. Kulie T, Groff A, Redmer J, Hounshell J, Schrager S, Journal of the American Board of Family Medicine: JABFM 2009 22 6 698 706 19897699
115. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Cranney A, Weiler HA, O'Donnell S, Puil L, The American journal of clinical nutrition 2008 88 2 513S 519S 18689393
116. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Osborne JE, Hutchinson PE, The British journal of dermatology 2002 147 2 197 213 12174089
117. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD, Haile RW, et al. The New England journal of medicine 1994 331 3 141 147 8008027 (Pubitemid 24209563)
118. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR, Cancer research 1988 48 16 4701 4705 3293777
119. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Ponz de Leon M, Roncucci L, Scandinavian journal of gastroenterology Supplement 1997 222 72 75 9145453 (Pubitemid 27196266)
120. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M, et al. Diseases of the colon and rectum 1993 36 3 227 234 8449125 (Pubitemid 23077909)
121. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, Gratten H, Lambert J, Newland RC, Ngu M, Russell A, et al. Journal of the National Cancer Institute 1995 87 23 1760 1766 7473832
122. Antioxidant supplements for preventing gastrointestinal cancers. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C, Cochrane Database Syst Rev 2008 3 D004183
123. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Buring JE, Manson JE, Journal of the National Cancer Institute 2009 101 1 14 23 19116389
124. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE, JAMA: the journal of the American Medical Association 2005 294 1 56 65 (Pubitemid 41002839)
125. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, et al. JAMA: the journal of the American Medical Association 2005 293 11 1338 1347 (Pubitemid 40381486)
126. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr, Journal of the
127. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S, Archives of internal medicine 2004 164 21 2335 2342 15557412 (Pubitemid 39532244)
128. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999 8 6 489 493 24021221 (Pubitemid 29270331)
129. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P, JAMA: the journal of the American Medical Association 2003 290 4 476 485 (Pubitemid 37430501)
130. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slate EH, Fischbach LA, Marshall JR, Clark LC, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 11 7 630 639 24021221 (Pubitemid 34760821)
131. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, et al. The New England journal of medicine 1996 334 18 1145 1149 8602179 (Pubitemid 26137972)